These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 32255280
1. Comparative Routine Therapeutic Drug Monitoring of Mycophenolic Acid in human Plasma with HPLC-UV and Isotope Dilution LC-MS/MS. Paal M, Habler K, Northoff B, Vogeser M. Clin Lab; 2020 Apr 01; 66(4):. PubMed ID: 32255280 [Abstract] [Full Text] [Related]
5. Therapeutic drug monitoring of mycophenolic acid (MPA) using volumetric absorptive microsampling (VAMS) in pediatric renal transplant recipients: ultra-high-performance liquid chromatography-tandem mass spectrometry analytical method development, cross-validation, and clinical application. Kocur A, Rubik J, Czarnowski P, Czajkowska A, Marszałek D, Sierakowski M, Górska M, Pawiński T. Pharmacol Rep; 2023 Aug 01; 75(4):1026-1042. PubMed ID: 37452967 [Abstract] [Full Text] [Related]
6. Simultaneous Determination of Protein-Unbound Cyclosporine A and Mycophenolic Acid in Kidney Transplant Patients Using Liquid Chromatography-Tandem Mass Spectrometry. Bittersohl H, Herbinger J, Wen M, Renders L, Steimer W, Luppa PB. Ther Drug Monit; 2017 Jun 01; 39(3):211-219. PubMed ID: 28328764 [Abstract] [Full Text] [Related]
7. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients. Blanchet B, Taieb F, Conti F, Abbas H, Seydi I, Harcouet L, Dauphin A, Calmus Y, Tod M. Liver Transpl; 2008 Dec 01; 14(12):1745-51. PubMed ID: 19025918 [Abstract] [Full Text] [Related]
8. A Comparison of the Immunochemical Methods, PETINIA and EMIT, With That of HPLC-UV for the Routine Monitoring of Mycophenolic Acid in Heart Transplant Patients. Kunicki PK, Pawiński T, Boczek A, Waś J, Bodnar-Broniarczyk M. Ther Drug Monit; 2015 Jun 01; 37(3):311-8. PubMed ID: 25380305 [Abstract] [Full Text] [Related]
9. Monitoring of mycophenolate acid in serum or plasma using LC tandem mass spectrometry. Hammett-Stabler CA, Geis DC, Ritchie JC, Papadea C. Methods Mol Biol; 2010 Jun 01; 603():379-87. PubMed ID: 20077090 [Abstract] [Full Text] [Related]
10. Therapeutic Drug Monitoring of Mycophenolic Acid. Dasgupta A. Adv Clin Chem; 2016 Jun 01; 76():165-84. PubMed ID: 27645819 [Abstract] [Full Text] [Related]
11. A high-throughput U-HPLC-MS/MS assay for the quantification of mycophenolic acid and its major metabolites mycophenolic acid glucuronide and mycophenolic acid acyl-glucuronide in human plasma and urine. Klepacki J, Klawitter J, Bendrick-Peart J, Schniedewind B, Heischmann S, Shokati T, Christians U, Klawitter J. J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb 01; 883-884():113-9. PubMed ID: 21839692 [Abstract] [Full Text] [Related]
12. Quantification of Mycophenolic Acid in Plasma by High Performance Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Aravamudhan A, Johnson CL, Seegmiller JC. Methods Mol Biol; 2024 Feb 01; 2737():329-336. PubMed ID: 38036834 [Abstract] [Full Text] [Related]
13. Quantification of mycophenolic acid and glucuronide metabolite in human serum by HPLC-tandem mass spectrometry. Annesley TM, Clayton LT. Clin Chem; 2005 May 01; 51(5):872-7. PubMed ID: 15746301 [Abstract] [Full Text] [Related]
14. Liquid chromatography-tandem mass spectrometry method for the quantification of mycophenolic acid and its phenolic glucuronide in saliva and plasma using a standardized saliva collection device. Wiesen MH, Farowski F, Feldkötter M, Hoppe B, Müller C. J Chromatogr A; 2012 Jun 08; 1241():52-9. PubMed ID: 22552204 [Abstract] [Full Text] [Related]
15. Quantification of mycophenolic acid in human plasma by liquid chromatography with time-of-flight mass spectrometry for therapeutic drug monitoring. Antunes NJ, Ince N, Raymond J, Kipper K, Couchman L, Holt DW, De Nucci G, Johnston A. Biomed Chromatogr; 2021 Mar 08; 35(3):e5011. PubMed ID: 33119895 [Abstract] [Full Text] [Related]
16. Positive bias in mycophenolic acid concentrations determined by the CEDIA assay compared to HPLC-UV method: is CEDIA assay suitable for therapeutic drug monitoring of mycophenolic acid? Dasgupta A, Johnson M. J Clin Lab Anal; 2013 Jan 08; 27(1):77-80. PubMed ID: 23325745 [Abstract] [Full Text] [Related]
17. Validation of an LC-MS/MS method to determine five immunosuppressants with deuterated internal standards including MPA. Buchwald A, Winkler K, Epting T. BMC Clin Pharmacol; 2012 Jan 11; 12():2. PubMed ID: 22236286 [Abstract] [Full Text] [Related]
18. Inclusion of MPA and in a rapid multi-drug LC-tandem mass spectrometric method for simultaneous determination of immunosuppressants. Ceglarek U, Casetta B, Lembcke J, Baumann S, Fiedler GM, Thiery J. Clin Chim Acta; 2006 Nov 11; 373(1-2):168-71. PubMed ID: 16806142 [Abstract] [Full Text] [Related]
19. Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring. Prémaud A, Rousseau A, Le Meur Y, Lachâtre G, Marquet P. Ther Drug Monit; 2004 Dec 11; 26(6):609-19. PubMed ID: 15570184 [Abstract] [Full Text] [Related]
20. Simultaneous measurement of amiodarone and desethylamiodarone in human plasma and serum by stable isotope dilution liquid chromatography-tandem mass spectrometry assay. Kuhn J, Götting C, Kleesiek K. J Pharm Biomed Anal; 2010 Jan 05; 51(1):210-6. PubMed ID: 19720490 [Abstract] [Full Text] [Related] Page: [Next] [New Search]